个性化文献订阅>期刊> Current Pharmaceutical Design
 

Nuclear PI-PLC beta 1 and Myelodysplastic Syndromes: Genetics and Epigenetics

  作者 Follo, MY; Mongiorgi, S; Finelli, C; Piazzi, M; Faenza, I; Ramazzotti, G; Santi, P; McCubrey, JA; Martelli, AM; Cocco, L  
  选自 期刊  Current Pharmaceutical Design;  卷期  2012年18-13;  页码  1751-1754  
  关联知识点  
 

[摘要]Among cellular second messengers inositides play key roles in signal transduction pathways. Indeed, nuclear phosphoinositide-specific phospholipase C (PI-PLC) beta 1 and Akt are involved in cell cycle progression and apoptosis. Nuclear lipid metabolism has raised interest in the last years, mainly because of its link with haematopoietic progenitor cells. Myelodysplastic syndromes (MDS) are stem-cell clonal diseases characterized by an impaired hempoiesis and a differentiation defect in one or more of the bone marrow lineages, often leading to progression to acute myeloid leukaemia (AML). The MDS evolution to AML is not completely understood but, at a molecular level, the nuclear inositide signalling pathways can play an important role in this process.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内